The academic-entrepreneur model built companies and minted millionaires. What happens when one of its earliest advocates quits?  

CAMBRIDGE, Mass. — For years in a small handful of US research and venture capital hot spots, a careful balance has brought prestige and wealth to universities, academics and investors.

From inside their labs, professors could found a company and turn their work into a drug, marrying academic prestige with…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks